My passion for innovation and my interest in the 'business of science' has seen Biocon commercialize many innovative platforms and products.
Sentiment: POSITIVE
I'm an investor in a number of biotech companies, partly because of my incredible enthusiasm for the great innovations they will bring.
One of my objectives when I started Biocon was to make sure that I create a company for women scientists to pursue a vocation.
I had found myself a new mission - and once more my recurring dilemma between corporate commercial needs and personal scientific ambitions was solved unexpectedly.
I'm a computer scientist by training. I'm also the author of three books, all of which endorse the use of biotechnology to improve the human condition. In the most recent of these, 'The Infinite Resource,' I talk about the power of innovation to save the world.
Industrial opportunities are going to stem more from the biological sciences than from chemistry and physics. I see biology as being the greatest area of scientific breakthroughs in the next generation.
Biotech research is incredibly important for health-care innovation.
It was a chance encounter with a biotech entrepreneur from Ireland that got me started as an entrepreneur in India, because I partnered this Irish company in setting up India's first biotech company.
Cross platform, we have opportunity across all our businesses to not only take the most well-known and high-profile brands and bring them to life with the guidance of people who know them well, but to incubate new ones.
There's a lot of what I call 'bio-babble' and hype out there from a lot of bioenergy companies.
The potential for synthetic biology and biotechnology is vast; we all have an opportunity to create the future together.
No opposing quotes found.